AxoGen Inc
NASDAQ:AXGN

Watchlist Manager
AxoGen Inc Logo
AxoGen Inc
NASDAQ:AXGN
Watchlist
Price: 6.83 USD -2.43% Market Closed
Updated: Jun 1, 2024

AxoGen Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

AxoGen Inc
Total Equity Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
AxoGen Inc
NASDAQ:AXGN
Total Equity
$93.2m
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Total Equity
$25.6B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
17%
Boston Scientific Corp
NYSE:BSX
Total Equity
$19.9B
CAGR 3-Years
8%
CAGR 5-Years
17%
CAGR 10-Years
12%
Stryker Corp
NYSE:SYK
Total Equity
$19.2B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Total Equity
$38.8B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
5%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Equity
$14B
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
14%

See Also

What is AxoGen Inc's Total Equity?
Total Equity
93.2m USD

Based on the financial report for Mar 31, 2024, AxoGen Inc's Total Equity amounts to 93.2m USD.

What is AxoGen Inc's Total Equity growth rate?
Total Equity CAGR 5Y
-8%

Over the last year, the Total Equity growth was -4%. The average annual Total Equity growth rates for AxoGen Inc have been -8% over the past three years , -8% over the past five years .